IRIS
DE VITA, Ferdinando
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 15.970
NA - Nord America 7.522
AS - Asia 6.437
SA - Sud America 1.033
AF - Africa 91
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 7
Totale 31.071
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 9.985
US - Stati Uniti d'America 7.319
SG - Singapore 2.188
IE - Irlanda 1.734
CN - Cina 1.388
HK - Hong Kong 1.004
IT - Italia 905
BR - Brasile 868
VN - Vietnam 778
UA - Ucraina 763
GB - Regno Unito 667
DE - Germania 613
FR - Francia 404
KR - Corea 386
FI - Finlandia 321
SE - Svezia 213
IN - India 172
TR - Turchia 146
CA - Canada 141
GR - Grecia 137
JP - Giappone 132
AR - Argentina 54
AT - Austria 46
PL - Polonia 42
MX - Messico 41
BD - Bangladesh 40
NL - Olanda 40
ID - Indonesia 39
EC - Ecuador 28
IQ - Iraq 27
BE - Belgio 25
ZA - Sudafrica 22
ES - Italia 20
PK - Pakistan 20
CL - Cile 18
VE - Venezuela 15
MA - Marocco 14
PE - Perù 14
SC - Seychelles 13
CO - Colombia 12
CZ - Repubblica Ceca 11
AL - Albania 10
PH - Filippine 10
SA - Arabia Saudita 10
IL - Israele 9
PY - Paraguay 9
TH - Thailandia 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
BO - Bolivia 7
DO - Repubblica Dominicana 7
KZ - Kazakistan 7
NP - Nepal 7
TN - Tunisia 7
UY - Uruguay 7
AZ - Azerbaigian 6
EG - Egitto 6
IR - Iran 6
KE - Kenya 6
NZ - Nuova Zelanda 6
AU - Australia 5
EU - Europa 5
JO - Giordania 5
LB - Libano 5
LT - Lituania 5
MY - Malesia 5
PT - Portogallo 5
SN - Senegal 5
CG - Congo 3
ET - Etiopia 3
HN - Honduras 3
JM - Giamaica 3
KG - Kirghizistan 3
LU - Lussemburgo 3
LV - Lettonia 3
RS - Serbia 3
AO - Angola 2
BG - Bulgaria 2
BH - Bahrain 2
BY - Bielorussia 2
CR - Costa Rica 2
CY - Cipro 2
DZ - Algeria 2
LK - Sri Lanka 2
MK - Macedonia 2
OM - Oman 2
PA - Panama 2
QA - Qatar 2
RO - Romania 2
TW - Taiwan 2
UG - Uganda 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CH - Svizzera 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
Totale 31.055
Salva come PNG Salva come JPEG
Città #
Moscow 3.641
Dublin 1.726
Jacksonville 1.176
Hong Kong 997
Santa Clara 959
Singapore 912
San Jose 823
Chandler 805
Seoul 371
Ashburn 270
Princeton 244
Ho Chi Minh City 239
Medford 216
Hanoi 186
New York 182
Hefei 168
Beijing 150
Naples 144
Caserta 143
Ann Arbor 142
Roxbury 141
Boardman 140
Bremen 134
San Mateo 125
Bengaluru 122
Helsinki 116
Munich 100
Elora 97
Wilmington 97
Dallas 78
Woodbridge 74
Los Angeles 71
São Paulo 69
The Dalles 66
Nanjing 65
Des Moines 52
Dong Ket 52
Cambridge 51
Nuremberg 49
Napoli 46
Milan 39
Jinan 37
Da Nang 36
Rome 30
Mountain View 29
Rio de Janeiro 29
Haiphong 27
Council Bluffs 26
Kraków 26
Amsterdam 24
Brussels 24
Tianjin 24
Belo Horizonte 23
Vienna 23
Houston 22
Orem 20
Tokyo 20
Curitiba 19
Norwalk 19
Aversa 18
Hangzhou 18
Turku 18
Zhengzhou 18
Biên Hòa 17
Changsha 16
Shenyang 16
Brasília 15
Chennai 15
Düsseldorf 15
Guangzhou 15
Jakarta 15
Aiello Del Sabato 14
Atlanta 14
Hải Dương 14
London 13
Nanchang 13
Shanghai 13
Thái Nguyên 13
Auburn Hills 12
Ottawa 12
Thái Bình 12
Guarulhos 11
Hillsboro 11
Istanbul 11
Lanzhou 11
Manchester 11
Porto Alegre 11
Taizhou 11
Toronto 11
Brno 10
Brooklyn 10
Chicago 10
Ercolano 10
Frankfurt am Main 10
Guayaquil 10
Lima 10
Salvador 10
San Francisco 10
Baghdad 9
Falkenstein 9
Totale 16.258
Salva come PNG Salva come JPEG
Nome #
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis 208
ONCOLOGIA MEDICA 206
Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy. 201
MicroRNA-423-5p promotes autophagy in cancer cells and is increased in serum from hepatocarcinoma patients treated with sorafenib 192
Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis 181
Adjuvant chemoradiotherapy in patients with stage III-IV radically resected gastric cancer: a pilot study 181
Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma—a pilot study. Curr Oncol 21, 3, june 2014 125-133 179
A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant 178
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients 177
A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer 177
Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience 177
Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer: A propensity score-matched analysis 173
A possible connective tissue primary lymphoepithelioma-like carcinoma (LELC). 172
Amifostine: a selective cytoprotective agent of normal tissues from chemo-radiotherapy induced toxicity (Review) 171
Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors 170
Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis 169
Microsatellite Status Detection in Gastrointestinal Cancers: PCR/NGS Is Mandatory in Negative/Patchy MMR Immunohistochemistry 169
CD 26-positive/CD 326-negative circulating cancer cells as prognostic markers for colorectal cancer recurrence 168
Comparison of the current AJCC-TNM numeric-based with a new anatomical location-based lymph node staging system for gastric cancer: A western experience 168
Clinical management of advanced gastric cancer: Role of new molecular drugs. 166
Antitumor activity of sorafenib in human cancer cell lines with acquired resistance to EGFR and VEGFR tyrosine kinase inhibitors. 164
Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma. 163
Analysis of neurothelin expression in neoplastic cells derived from gastrointestinal tract tumors 163
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study) 162
Antitumor activity of ZD6474, a vascular endothelial growth factor-2 and epidermal growth factor receptor small molecule tyrosine kinase inhibitor, in combination with SC-236, a cyclooxygenase-2 inhibitor 161
Combined CD133/CD44 Expression as a Prognostic Indicator of Disease-Free Survival in Patients With Colorectal Cancer. 161
A true splenic cyst producing carboydrate antigen 19-9 and cancer antigen 50 and 125,but not interleukin 10 160
Different Biomarkers address different colorectal cancer stem cell populations: who's the killer? 160
Behavior of circulating CD4+CD25+FOXP3* regulatory T cells in colon cancer patients undergoing surgery 160
Naples Prognostic Score Predicts Tumor Regression Grade in Resectable Gastric Cancer Treated with Preoperative Chemotherapy 160
Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment 159
Liquid Biopsy at Home: Delivering Precision Medicine for Patients with Cancer During the Covid-19 Pandemic 157
Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC 156
Pancreatic fistula following pancreatoduodenectomy. Evaluation of different surgical approaches in the management of pancreatic stump. Literature review. 154
Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: relationship with response to therapy and survival 154
A true splenic cyst producing carbohydrate antigen 19-9 and cancer antigens 50 and 125, but not interleukin 10 150
Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer 150
Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review. 150
antitumor activity of zd6474, a VEGFR-2 and EGFR small molecule tyrosine kinase inhibitor in combination with SC-236, a cicloxigenase-2 inhibitor 149
Conversion chemotherapy followed by epatic resection in colorectal cancer with initially unresectable liver-limited metastases 149
Circulating levels of interleukin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: relationship with radicality and outcome 148
Analysis of interleukin-2/interleukin-2 receptor system in advanced non-small-cell lung cancer 148
Predictive biomarkers along gastric cancer pathogenetic pathways 148
Treatment of gastric cancer. 147
An intramedullary "flame" recognized as being an intramedullary spinal cord metastasis from esophageal cancer 147
Clinical practice use of liquid biopsy to identify RAS/BRAF mutations in patients with metastatic colorectal cancer (mCRC): A single institution experience 146
Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy 145
Correlation between efficacy and skin rash occurrence following treatment with the epidermal growth factor receptor inhibitor cetuximab: a single institution retrospective analysis 144
Adult Wilms' tumor: a case report 144
Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer 144
Inflammatory and nutritional status is a predictor of long-term outcome in patients undergoing surgery for gastric cancer. Validation of the Naples prognostic score. 144
Discrepancy of p16 immunohistochemical expression and HPV RNA in penile cancer. A multiplex in situ hybridization/immunohistochemistry approach study 144
Immunotherapy in Penile Squamous Cell Carcinoma: Present or Future? Multi-Target Analysis of Programmed Cell Death Ligand 1 Expression and Microsatellite Instability 143
Adjuvant Treatment in Pancreatic Cancer: Shaping the Future of the Curative Setting 143
DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer 141
A rare case of extraovarian primary peritoneal carcinoma in a 72 year-old woman 141
Neutrophil to lymphocyte ratio is a strong predictor of tumor recurrence in early colon cancers: a propensity score-matched analysis 141
Novel Therapeutic Opportunities in Neoadjuvant Setting in Urothelial Cancers: A New Horizon Opened by Molecular Classification and Immune Checkpoint Inhibitors 141
Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors 140
Clinical efficacy of sequential treatments in KRASG12C-mutant metastatic colorectal cancer: findings from a real-life multicenter Italian study (CRC-KR GOIM) 139
Identification of Tissue miRNA Signatures for Pancreatic Ductal Adenocarcinoma 138
A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases. 138
Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: A randomised study by the Southern Italy Cooperative Oncology Group 137
Anthracycline-induced cardiotoxicity: monitoring and prevention of the lesion 137
Farmacogenomica e cancro colorettale 137
Hepatoid carcinoma colliding with a liposarcoma of the left colon serosa presenting as an abdominal mass 137
Is complete mesocolic excision with central vascular ligation safe and effective in the surgical treatment of right-sided colon cancers ? A prospective study. 137
HER2-Low Status Does Not Affect Survival Outcomes of Patients with Metastatic Breast Cancer (MBC) Undergoing First-Line Treatment with Endocrine Therapy plus Palbociclib: Results of a Multicenter, Retrospective Cohort Study 136
Analysis of recovery time indexes in 5-fluorouracil-treated cancer patients 136
Three dimensional primary cultures for selecting human breast cancers that are sensitive to the anti-tumor activity of ipatasertib or taselisib in combination with anti-microtubule cytotoxic drugs 136
The over-the-scope-clip (OTSC) system is effective in the treatment of chronic esophago-jejunal anastomotic leakage 135
Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial 134
Complete response to preoperative chemoradiation and survival in esophageal cancer : a pooled analysis of three singe-institution phase II trials. 134
Triple-Negative Breast Cancers: Systematic Review of the Literature on Molecular and Clinical Features with a Focus on Treatment with Innovative Drugs 132
Adjuvant chemotherapy of gastric cancer: which regimen? 131
TRATTAMENTO MULTIMODALE DEL CA ESOFAGEO. NOSTRA ESPERIENZA 131
Comprehensive genomic profiling by liquid biopsy captures tumor heterogeneity and identifies cancer vulnerabilities in patients with RAS/BRAF wild-type metastatic colorectal cancer in the CAPRI 2-GOIM trial 130
Synergistic Antitumor Activity of Sorafenib in Combination with Epidermal Growth Factor Receptor Inhibitors in Colorectal and Lung Cancer Cells 130
Cardiotossicità da antracicline: attualità e prospettive 130
Atypycal presentation of Merkel cell carcinoma positive to polyomavirus DNA detection: experience from a single center 130
PROSPETTIVE DELLA TERAPIA NEOADIUVANTE NEL CANCRO ESOFAGEO AVANZATO 130
Assessment of the DNA Mismatch Repair System Is Crucial in Colorectal Cancers Necessitating Adjuvant Treatment: A Propensity Score-Matched and Win Ratio Analysis 129
Serum interleukin-10 is an independent prognostic factor in advanced solid tumors 129
Pattern of recurrence and overall survival in esophagogastric cancer after perioperative FLOT and clinical outcomes in MSI-H population: the PROSECCO Study 128
TRASTUZUMAB RESISTANCE IN BREAST CANCER 128
Vertebral carcinomatosis eleven years after advanced gastric cancer resection: A case report. 127
PERSPECTIVES OF THE NEOADJUANT THERAPY IN ADVANCED ESOPHAGEAL CARCINOMA 127
Pegylated liposomal doxorubicin: pharmacologic and clinical evidence of potent antitumor activity with reduced anthracyclina-induced cardiotoxicity (review) 127
Increased circulating levels of vascular endothelial growth factor C can predict outcome in resectable gastric cancer patients 127
Immune-Based Therapy in Triple-Negative Breast Cancer: From Molecular Biology to Clinical Practice 126
Presence of tumor deposits is a strong indicator of poor outcome in patients with stage III colorectal cancers undergoing radical surgery 126
Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: Relationship with prognosis 126
The lymph node ratio is a powerful prognostic factor of node-positive colon cancers undergoing potentially curative surgery. 125
Il linfoma primitivo della parotide: una localizzazione infrequente 125
p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate 125
Phosphatidylinositol 3-kinase (PI3Ka)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells 125
Integrated therapy in localized gastric cancer: targeted and tailored approach. 124
Serum vascular endothelial growth factor (VEGF)levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancer 124
ENDOSONOGRAPHIC ASSESSMENT OF RESPONSE TO RESPONSE TO NEOAJUVANT CHEMOTHERAPY IN PREDICTING SURVIVAL OF ESOPHAGEAL CARCINOMA PATIENTS 124
Determination of molecular marker expression can predict clinical outcome in colon carcinomas 123
Totale 14.814
Salva come PNG Salva come JPEG
Categoria #
all - tutte 103.889
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.889
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021487 0 0 0 0 0 0 0 0 0 217 171 99
2021/20221.453 134 10 16 24 528 8 29 48 51 61 125 419
2022/20233.327 429 61 45 262 363 256 15 194 1.587 14 55 46
2023/20241.307 107 36 59 117 444 166 11 31 16 19 95 206
2024/20253.993 37 109 38 110 618 512 491 367 567 549 306 289
2025/202616.511 593 826 815 843 1.354 9.303 792 931 722 332 0 0
Totale 31.667